PAD Clinical Trial
Official title:
Safety and Efficacy of the Drug Coated Balloon (DCB) for the Treatment of the Superficial Femoral Artery (SFA) Ischemic Vascular Disease in Symptomatic Patients Presenting With TASC C and D Lesions: a Pilot Study
The study is aimed at collecting preliminary safety and efficacy data related to the use of
Drug Coated Balloon (DCB) technology for the treatment of symptomatic Superficial Femoral
Artery (SFA) ischemic vascular disease in patients presenting with long lesions.
The present clinical evaluation is intended as a prospective observational data collection
of patient treatment in full accordance with institution standard practice and utilizing an
approved (CE marked) DCB currently available on the market.
The present study is designed as a prospective, open label, observational study.
The study will collect information about the medical care patients receive during their
planned procedure. No additional testing or procedures will be done.
Patients elected for endovascular revascularization with DCB will be asked their written
consent to the use of their personal data.
Revascularization will be performed as per standard procedure of the sites. After discharge
all patients will attend clinic visits at 30 days (±14 days), 6 months (±30 days), 12 months
(±30 days), 24 and 36 months (±30 days). Angiographic follow-up will be performed in
symptomatic patients, as clinically indicated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03157531 -
Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD
|
N/A | |
| Recruiting |
NCT03668353 -
Recombinant SeV-hFGF2/dF Injection for PAOD
|
Phase 1 | |
| Not yet recruiting |
NCT04108806 -
Study of Peripheral Arterial Calcification
|
N/A | |
| Completed |
NCT02561299 -
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
|
N/A | |
| Completed |
NCT01355406 -
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
|
N/A | |
| Recruiting |
NCT06239493 -
IVUS-Guided Treatment for Percutaneous Vascular Interventions
|
||
| Active, not recruiting |
NCT00390767 -
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
|
Phase 1/Phase 2 | |
| Completed |
NCT02907203 -
Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
|
||
| Recruiting |
NCT03686228 -
Treatment of No-option CLI by G-CSF-mobilized PB-MNC
|
N/A | |
| Recruiting |
NCT03683628 -
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
|
N/A | |
| Active, not recruiting |
NCT04204564 -
VISION and VQI Paclitaxel Safety Analysis
|
||
| Terminated |
NCT01341340 -
The ABSORB BTK (Below The Knee) Clinical Investigation
|
N/A | |
| Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
| Recruiting |
NCT03900832 -
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability
|
Early Phase 1 | |
| Completed |
NCT03452293 -
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
|
||
| Recruiting |
NCT05361967 -
Tack Optimized Balloon Angioplasty Post-Market Study
|
||
| Active, not recruiting |
NCT02500303 -
Influence of Diabetes on Lower Limb Amputation
|
N/A | |
| Completed |
NCT03358355 -
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT03516383 -
Pulse Wave Velocity Imaging in the Assessment of PAD
|
||
| Completed |
NCT03590769 -
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
|
Phase 1 |